Prime Medicine (PRME) Change in Account Payables (2021 - 2026)
Prime Medicine posted quarterly Change in Account Payables of $3.6 million for Q1 2026, up 88.54% year-on-year from $1.9 million in Q1 2025, and up 711.36% on a QoQ basis from -$581000.0 in Q4 2025.
Prime Medicine (PRME) has 6 years of Change in Account Payables data on file, last reported at $3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 88.54% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 6.26% YoY), and the FY2025 full-year result was $996000.0, up 118.95% from the prior year.
- Change in Account Payables for Q1 2026 stood at $3.6 million, up from -$581000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $5.8 million in Q3 2023 and bottomed at -$5.9 million in Q1 2024.
- The 5-year median for Change in Account Payables is $1.4 million (2022), against an average of $640529.4.
- The widest annual swing landed in 2023, when Change in Account Payables jumped 1535.66%; it then plunged 1066.67% in 2024.
- A 5-year view of Change in Account Payables shows it stood at $431000.0 in 2022, then jumped by 428.77% to $2.3 million in 2023, then climbed by 7.94% to $2.5 million in 2024, then plunged by 123.62% to -$581000.0 in 2025, then jumped by 711.36% to $3.6 million in 2026.
- The last three Change in Account Payables figures came in at $3.6 million (Q1 2026), -$581000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Prime Medicine | 601.24 Mn | 601.24 Mn | - | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55 Mn |
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | -581,000.00 |
| Dec 31, 2025 | -581,000.00 |
| Sep 30, 2025 | 3.04 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | -3.35 Mn |
| Jun 30, 2025 | -3.35 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | -3.35 Mn |
| Jun 30, 2024 | -3.35 Mn |
| Mar 31, 2024 | -5.88 Mn |
| Mar 31, 2024 | -5.88 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 5.76 Mn |
| Sep 30, 2023 | 5.76 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | -504,000.00 |
| Mar 31, 2023 | -504,000.00 |
| Dec 31, 2022 | 431,000.00 |
| Dec 31, 2022 | 431,000.00 |
| Sep 30, 2022 | -401,000.00 |
| Sep 30, 2022 | -401,000.00 |
| Jun 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Dec 31, 2021 | 80,000.00 |
| Dec 31, 2021 | 80,000.00 |